glp-1 news october 21 2025 Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss GLP-1 trends 2025: real-world data,

2023 Jan;39(1):171-213

Emerging evidence indicates that certain probiotic strains can potently induce the expansion and enhance the functional activity of regulatory T cells

Future studies should explore strategies to preserve the benefits achieved with GLP1RAs and tirzepatide after treatment withdrawal

Kamachi K, Akiyama H, Zhao R, Zhang L, Gupta SK, Ostermann L, Mak PY, Otsuki Y, Nagano O, Saya H, Taguchi A, Thongon N, Colla S, Garcia-Manero G, Shuxin D, Lodi A, Carter B, Kornblau S, Andreeff M , Ishizawa J

Indications: Treatment resistant hypertension Most often used as a supplemental drug that is added on to a daily treatment regimen for patients with hypertension that is not adequately controlled by a combination of lifestyle modification, thiazide diuretic, plus an ACE inhibitor or Angiotensin receptor blocker (Brook & Townsend, 2026)

Wow, they dont respect personal preferences, wrote one Korean viewer